ArticleInternational ophthalmology2025
Constructing a disease-specific ceRNA coregulatory network for keratoconus diagnosis and landscape of the immune environment.
Article in International ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThe early diagnosis of keratoconus (KC) is crucial for making treatment decisions. Therefore, the purpose of this study was to determine the potential disease-specific gene biomarker and landscape the immune environment in KC.
methodsThe transcriptome data of KC was obtained from Gene Expression Omnibus (GEO) and ArrayExpress databases for next analysis. The differently expressed mRNAs, microRNAs and lncRNAs between KC and control groups were firstly identified and the disease-specific protein-protein interaction (PPI) network as well as competing endogenous RNA (ceRNA) coregulatory network were constructed to explore the underlying molecular mechanism of KC. Besides, ElasticNet algorithm was used to develop a diagnostic model and associated nomograms to improve diagnosis of KC. Finally, multiple deconvolution methodologies were applied to decode the immune environment of KC patients.
resultsIn brief, we constructed the disease-specific PPI and ceRNA networks in KC through integrative analyses. The pathway enrichment manifested that these networks were significantly associated with lipopolysaccharide, chemokine and inflammatory related pathways. Based on the ceRNA network, we constructed a diagnostic model and associated nomogram which manifested a good performance for diagnosis of KC. Moreover, contrasted to control groups, we obviously observed that a distinct immune microenvironment existed in KC patients. Via single-cell sequencing analysis, we found that immune cells (Monocytes, Macrophages, and T cells) were strongly connected with corneal cells in KC patients.
conclusionsIn sum, we systematically constructed a diagnostic model and associated nomogram which provided novel biomarkers for the early detection of KC. Besides, our study comprehensively displayed the immune microenvironment of KC which provided new insights for understanding the molecular mechanism of KC.
Indexed as
Identifiers
40119981What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.